Evolution of Paroxysmal Atrial Fibrillation to Persistent or Permanent Atrial Fibrillation: Predictors of Progression
- PMID: 28496630
- PMCID: PMC5398837
- DOI: 10.4022/jafib.191
Evolution of Paroxysmal Atrial Fibrillation to Persistent or Permanent Atrial Fibrillation: Predictors of Progression
Abstract
Introduction: Paroxysmal atrial fibrillation (PAF) eventually progresses to persistent and permanent AF. The predictors of progression from PAF to persistent and permanent AF are poorly understood. Methods: Electronic medical records of 437 patients with PAF were reviewed in a retrospective cohort study. Patients were followed in time and progression to persistent/permanent AF was recorded. Demographic, clinical and echocardiographic information was collected. A logistic regression analysis was performed to identify predictors of progression to persistent/permanent AF. Results: Over a mean duration of 57.3±55.9 months, 32.4% of patients progressed to persistent/permanent AF. Mean age of the population was 67.9±13.4 years with 57% males and 92% Caucasian. Univariate analysis identified higher body higher mass index (BMI), cardiomyopathy, diabetes, valvular heart disease (VHD), larger left atrial size (LA) and higher pulmonary artery pressure as predictors of progression. Multivariate logistic regression analysis larger left atrial size (OR 1.46, CI 1.05-2.04, P 0.002), cardiomyopathy (OR 2, CI 1.1- 3.3, P 0.003), and moderate to severe valvular heart disease (OR 3.3, CI 1.4-5, P 0.008) as significant predictors of progression to persistent/permanent AF. Conclusions: Our study shows that PAF patients with larger LA, valvular heart disease and cardiomyopathy predict progression of PAF to persistent/permanent AF. Higher BMI and cardiomyopathy predicted progression to persistent AF while larger LA size and VHD predicted progression to permanent AF.
Figures
Similar articles
-
Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation.Pacing Clin Electrophysiol. 2014 Mar;37(3):345-55. doi: 10.1111/pace.12264. Epub 2013 Nov 14. Pacing Clin Electrophysiol. 2014. PMID: 24236932
-
Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation.Europace. 2022 Sep 1;24(8):1223-1228. doi: 10.1093/europace/euac031. Europace. 2022. PMID: 35355079
-
Long-term Prognosis of Paroxysmal Atrial Fibrillation and Predictors for Progression to Persistnt or Chronic Atrial Fibrillation in the Korean Population.J Korean Med Sci. 2015 Jul;30(7):895-902. doi: 10.3346/jkms.2015.30.7.895. Epub 2015 Jun 10. J Korean Med Sci. 2015. PMID: 26130952 Free PMC article.
-
Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis.Heart Rhythm. 2019 Apr;16(4):502-510. doi: 10.1016/j.hrthm.2018.10.022. Epub 2018 Oct 24. Heart Rhythm. 2019. PMID: 30366160
-
[Interventional therapy of atrial fibrillation: possibilities and limitations].Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S48-54. doi: 10.1055/s-0030-1249209. Epub 2010 Mar 10. Dtsch Med Wochenschr. 2010. PMID: 20221979 Review. German.
Cited by
-
Label-free Imaging of Myocardial Remodeling in Atrial Fibrillation Using Nonlinear Optical Microscopy: A Feasibility Study.J Atr Fibrillation. 2018 Feb 28;10(5):1644. doi: 10.4022/jafib.1644. eCollection 2018 Feb. J Atr Fibrillation. 2018. PMID: 29988238 Free PMC article.
-
Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.Cardiovasc Diabetol. 2021 Dec 7;20(1):230. doi: 10.1186/s12933-021-01423-2. Cardiovasc Diabetol. 2021. PMID: 34876114 Free PMC article.
-
Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study.J Geriatr Cardiol. 2020 Feb;17(2):74-84. doi: 10.11909/j.issn.1671-5411.2020.02.002. J Geriatr Cardiol. 2020. PMID: 32165880 Free PMC article.
-
Arginine derivatives in atrial fibrillation progression phenotypes.J Mol Med (Berl). 2020 Jul;98(7):999-1008. doi: 10.1007/s00109-020-01932-9. Epub 2020 Jun 6. J Mol Med (Berl). 2020. PMID: 32504111 Free PMC article.
-
The Role of Echocardiography as a Predictor of the Incidence and Progression of Atrial Fibrillation.J Atr Fibrillation. 2012 Oct 6;5(3):713. doi: 10.4022/jafib.713. eCollection 2012 Oct-Nov. J Atr Fibrillation. 2012. PMID: 28496781 Free PMC article. Review.
References
-
- Wolf P A, Dawber T R, Thomas H E, Kannel W B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978 Oct;28 (10):973–7. - PubMed
-
- Krahn A D, Manfreda J, Tate R B, Mathewson F A, Cuddy T E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am. J. Med. 1995 May;98 (5):476–84. - PubMed
-
- Benjamin E J, Wolf P A, D'Agostino R B, Silbershatz H, Kannel W B, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 08;98 (10):946–52. - PubMed
-
- Psaty B M, Manolio T A, Kuller L H, Kronmal R A, Cushman M, Fried L P, White R, Furberg C D, Rautaharju P M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997 Oct 07;96 (7):2455–61. - PubMed
-
- Lloyd-Jones Donald M, Wang Thomas J, Leip Eric P, Larson Martin G, Levy Daniel, Vasan Ramachandran S, D'Agostino Ralph B, Massaro Joseph M, Beiser Alexa, Wolf Philip A, Benjamin Emelia J. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004 Aug 31;110 (9):1042–6. - PubMed
LinkOut - more resources
Full Text Sources